ARTICLE | Clinical News
Dutetrabenazine regulatory update
November 24, 2014 8:00 AM UTC
FDA granted Orphan Drug designation to Auspex’s SD-809 to treat Huntington’s disease (HD). The deuterium-substituted analog of tetrabenazine, a vesicular monoamine, is in Phase III testing to treat ch...